ULB Hôpital Erasme - FNRS
" Genetic modifiers of the clinical response to infection by SARS-CoV-2 (COVID-19). The project is part of a global effort of the human genetics community to generate, share and analyze data to learn the genetic determinants of COVID-19 susceptibility, severity and outcomes in all patients, as well as identify genetic errors that make some younger patients especially vulnerable to the virus. DNA samples and clinical data for COVID-19 patients are collected for GWAS analysis, whole exome, and/or whole genome sequencing. Such discoveries could help to generate hypotheses for drug repurposing, identify individuals at unusually high or low risk, and contribute to global knowledge of the biology of SARS-CoV-2 infection and disease. "
Funding: -ULB -Fondation Erasme
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it.